5 Healthcare Stocks to Buy Now According to Billionaire Louis Bacon

2. Guardant Health, Inc. (NASDAQ:GH)  

Moore Global Investments’ Stake Value: $52.29 million

Moore Global Investments’ 13F Portfolio: 0.79% 

Number of Hedge Fund Holders: 31

Guardant Health, Inc. (NASDAQ:GH) is a precision oncology company which provides cancer treatment through advanced analytics and testing. It reported earnings per share of -$1.06 in the third quarter, which missed analysts’ estimates by $0.17. Revenue for the quarter came in at $94.78 million, which beat analysts’ forecasts by $2.19 million.

Investors were seen off-loading Guardant Health, Inc. (NASDAQ:GH) stock, with 31 hedge funds holding positions in the company in Q3 2021, as compared to 49 hedge funds in the previous quarter.

On October 14, research firm Cowen maintained its ‘Outperform’ rating on Guardant Health, Inc. (NASDAQ:GH) stock, setting a $170 price target. This rating was provided by analyst Max Masucci.